PROTEINA
LIVE

Serial Number

97655467

Owner

Proteina Co., Ltd.

Attorney

Hun Joon Kim

First Use Date

Aug 5, 2015

Filing Date

Oct 31, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PROTEINA Trademark

Serial Number: 97655467

PROTEINA is a trademark filed by Proteina Co., Ltd. on October 31, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Proteina Co., Ltd. (4 trademarks)

11, Digital-ro 33-gil,

Entity Type: 03

Trademark Details

Filing Date

October 31, 2022

Registration Date

Not Registered

First Use Anywhere

August 5, 2015

First Use in Commerce

December 16, 2020

Published for Opposition

January 7, 2025

Goods & Services

Biochip for research or scientific purposes; Biochip analyzing apparatus, namely, optical imaging apparatus and instruments in conjunction with biochip for use in the study of proteins, peptides, DNA, aptamer, and RNA, not for medical purposes; Biochip sensors for research or scientific purposes; Cell chip inspection devices, namely, bio-cell chips for research or scientific purposes; Diagnostic apparatus for the detection of biomarkers for laboratory or research use; Protein analysis devices, namely, scientific apparatus and instruments for analyzing protein; Laboratory apparatus for analyzing biological pharmaceuticals; Scientific instruments for analyzing chemical and biological substances for the presence, absence, or quantity of target biologics and chemicals; Optical imaging apparatus and instruments for use in the study of proteins, peptides, DNA, aptamer, and RNA, not for medical purposes; Biosensors, namely, sensors for the purpose of scientific and diagnostic use for detecting the presence of multiple molecular substances; Diagnostic apparatus for the detection of proteins, DNA, and cells, not for medical purpose; Downloadable and recorded computer software for use in database generation, analysis, and management; Downloadable and recorded computer software for use in optical image and scientific data analysis; Downloadable images in the field of in vitro diagnostics, namely fluorescence images used for in vitro diagnostics; Analyzers for analyzing immunological activity for scientific purposes; Downloadable images in the field of in vitro diagnostics, namely fluorescence images used for in vitro diagnostics

Medical analysis for the diagnosis and treatment of persons; Medical analysis services for cancer diagnosis and prognosis; Provision of information regarding cancer prevention, screening, diagnosis, and treatment; Medical analysis services relating to cancer diagnoses; Analysis of human biometric data for medical purposes; Medical analysis services relevant to diagnoses; Medical information services relating to pharmaceuticals and medical products; Providing information services relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals for pharmaceuticals and medical products; Medical diagnostic services for testing and analysis; Analysis of human tissue for medical treatment; Medical testing for diagnostic or treatment purposes; Medical testing services relating to the diagnosis and treatment of disease; Clinical medical consultation services, namely, collecting, reviewing, analyzing, and reporting clinical data; Medical analysis services relating to treatment of patients

Analyzers for analyzing immunological activity for medical purposes; Analyzers for analyzing immunological activity for medical purposes; Medical apparatus and instrument for diagnostic use, namely, for medical diagnostic testing in the fields of cell-based testing; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for analyzing drug compounds; Immunoassay apparatus for detecting and analyzing biomarkers for medical diagnoses; Medical diagnostic apparatus for testing genomic materials, proteins, and cells relevant to diseases; Medical instruments for analyzing and identifying genomic materials, proteins, and cells; Medical diagnostic apparatus and instruments for detecting and analyzing diseases related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; Apparatus for medical, clinical, and diagnostic uses by analyzing genomic materials, proteins, and cells related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals; Computer displays and computer monitors and controllers used in direct association with medical diagnosis apparatuses during the process of diagnosis of a condition, namely genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals in an individual; Immunochemical testing apparatus for analyzing genomic materials, proteins, and cells for medical use; Automatic analyzers for disease diagnosis through inspection of genomic materials, proteins, and bio-samples for medical purposes; Apparatus for testing genomic materials, proteins, and cells relevant to diseases for medical purposes; Medical apparatus for testing genomic materials, proteins, and cells relevant to diseases, namely cancer and inflammatory disease; Apparatus for analyzing images for medical use, namely, fluorescence imaging apparatus for medical purpose; Medical diagnostic apparatus for analyzing and measuring genomic materials, proteins, and bio-samples; In vitro medical diagnostic devices for molecularly characterizing diseases related to genetic abnormality, protein abnormality, abnormal expression of proteins, and abnormality in protein interaction signals

Conducting early evaluation of new pharmaceutical compounds in development by others; Discovery and development of new drug candidate material; Scientific research for medical purposes in the area of cancerous diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical product evaluation, namely, technical assessment of the efficiency of pharmaceuticals; Medical research laboratory services for predicting disease; Pharmaceutical testing; Pharmaceutical research services; Provision of information regarding testing, inspection, and research of pharmaceutical products; Pharmaceutical product evaluation; Scientific research into medicine, health, and pharmacology; Human tissue analysis for the purpose of medical research; Design of devices intended for protein analysis; Protein analysis; Development of devices intended for protein analysis; Scientific and technological services, namely, scientific research in the field of biopharmaceuticals; Development of medical diagnostic instruments; Technological research in the field of biopharmaceuticals; Technical data analysis services for genomic and proteomic materials; Materials analysis; Development of computer software for big data processing; Biomedical research services; Biological research; Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials by proxy; Medical and scientific research, namely, conducting clinical studies of medicines for others; Pharmaceutical product evaluation; Scientific research services for medical purposes; Design of medical diagnostic apparatus and instruments; Development of computer software for use with medical equipment; Laboratory research services relating to pharmaceuticals; Design and development of image processing software; Medical analysis services relevant to drug development, laboratory testing, and scientific research; Providing medical and scientific research information services relating to pharmaceuticals and medical products in the fields of pharmaceuticals and genetics; Medical laboratory services for the analysis of samples taken from patients

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 5, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 27, 2024 CNSA
USE AMENDMENT ACCEPTED
Nov 27, 2024 IUAA
ASSIGNED TO LIE
Aug 6, 2024 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 1, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 1, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 1, 2024 COAR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2024 TROA
AMENDMENT TO USE PROCESSING COMPLETE
Feb 20, 2024 AUPC
USE AMENDMENT FILED
Feb 20, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Feb 20, 2024 EAAU
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 20, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 20, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2022 NWOS
NEW APPLICATION ENTERED
Nov 3, 2022 NWAP